ChickenStock Research
US SEC filing analysis
Read reviewed analyses of US SEC filings in English. Each report shows the form, the filing date, the scope of the analysis and the original filing.
Stock, IR and earnings analyses are available in Korean only. Korean analysis reports →
Find a company
Search by company name, ticker or report title.
US filing forms
Includes amendments (/A).Events and earnings releases · Reports events such as earnings releases, agreements and management changes. Not every 8-K is an earnings release.
US filing analysis · 8-K
Sorted by SEC acceptance time (filing date when unavailable). Page 20 · 30 shown · up to 30 per page
NWS
News Corp said the 2025 Repurchase Program authorizing the Company to acquire up to $1 billion in the aggregate of Class A common stock and Class B common stock was approved as of July 15, 2025.
US filing analysisUS8-K · Current reportPublished Oct 5, 2026SEC filing date Feb 17, 2026
HWM
Howmet Aerospace said on February 17, 2026 it priced an underwritten public offering of $400,000,000 aggregate principal amount of 3.750% notes due 2028, $300,000,000 aggregate principal amount of 3.900% notes due 2029, and $500,000,000 aggregate principal amount of 4.750% notes due 2036.
US filing analysisUS8-K · Current reportPublished Oct 4, 2026SEC filing date Feb 17, 2026
COF
Capital One said net charge-offs for domestic credit card loans for the month ended January 31, 2026 were $1,082 million, with a net charge-off rate of 5.04%.
US filing analysisUS8-K · Current reportPublished Oct 5, 2026SEC filing date Feb 17, 2026
APTV
Aptiv said on February 17, 2026 that Versigent Limited, a subsidiary of the company, publicly filed an amended preliminary Registration Statement on Form 10 with the U.S. Securities and Exchange Commission.
US filing analysisUS8-K · Current reportPublished Sep 30, 2026SEC filing date Feb 17, 2026
RCL
On February 12, 2026, Royal Caribbean Cruises Ltd. entered into an underwriting agreement with J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and PNC Capital Markets LLC, as representatives of the several underwriters, relating to the underwritten public offering of 2 series of Senior Notes.
US filing analysisUS8-K · Current reportPublished Sep 30, 2026SEC filing date Feb 13, 2026
News Corp said it is authorized to acquire up to US$1 billion in the aggregate of Class A and Class B common stock under the 2025 Repurchase Program as of July 15, 2025. The company said shareholder approval is not required.
US filing analysisUS8-K · Current reportPublished Sep 30, 2026SEC filing date Feb 13, 2026
NOC
Northrop Grumman said on February 12, 2026 its Board of Directors elected Admiral Christopher W. Grady to the Board effective that date and appointed him to the Audit and Risk Committee and the Policy Committee.
US filing analysisUS8-K · Current reportPublished Sep 30, 2026SEC filing date Feb 13, 2026
LVS
Las Vegas Sands said on February 12, 2026 its board of directors appointed Patrick Dumont, President and Chief Operating Officer, as Chairman, Chief Executive Officer, President and Treasurer, effective March 1, 2026.
US filing analysisUS8-K · Current reportPublished Oct 1, 2026SEC filing date Feb 13, 2026
IDXX
IDEXX Laboratories said on February 13, 2026 it received notice from director M. Anne Szostak of her intention to retire from the Board effective immediately following the 2026 Annual Meeting of Stockholders to be held on May 12, 2026.
US filing analysisUS8-K · Current reportPublished Oct 3, 2026SEC filing date Feb 13, 2026
HRL
Hormel Foods said Jacinth Smiley ceased serving as Executive Vice President and Chief Financial Officer effective October 26, 2025, with her last day of employment on November 30, 2025, and that the company entered into a Separation Agreement on February 11, 2026.
US filing analysisUS8-K/A · Current reportPublished Sep 30, 2026SEC filing date Feb 13, 2026
GS
Goldman Sachs said Kathryn H. Ruemmler has determined to retire from her roles as Chief Legal Officer and General Counsel of The Goldman Sachs Group, Inc.
US filing analysisUS8-K · Current reportPublished Oct 2, 2026SEC filing date Feb 13, 2026
GOOG
Alphabet closed concurrent underwritten public offerings of $20 billion aggregate principal amount of U.S. dollar-denominated senior notes (the U.S. Notes) and £5.5 billion aggregate principal amount of Sterling-denominated senior notes (the Sterling Notes) on February 13, 2026, the company said.
US filing analysisUS8-K · Current reportPublished Sep 30, 2026SEC filing date Feb 13, 2026
COR
Cencora completed the sale of $3.0 billion aggregate principal amount of Senior Notes on February 13, 2026, consisting of $500,000,000 each maturing in 2029, 2030 and 2033, $1,000,000,000 maturing in 2036, and $500,000,000 maturing in 2056.
US filing analysisUS8-K · Current reportPublished Sep 30, 2026SEC filing date Feb 13, 2026
YUM
Yum! Brands said Keith Barr, a member of the Board of Directors, informed the company on February 10, 2026 of his intention to resign from the Board, effective as of that date.
US filing analysisUS8-K · Current reportPublished Sep 30, 2026SEC filing date Feb 12, 2026
RSG
Republic Services said on February 10, 2026 its Board of Directors appointed Ian Craig, 53, to serve on the Board, effective immediately. He will initially be a member of the Board's Audit Committee and Sustainability & Corporate Responsibility Committee.
US filing analysisUS8-K · Current reportPublished Oct 3, 2026SEC filing date Feb 12, 2026
News Corp said the 2025 Repurchase Program authorizing the company to acquire up to $1 billion in the aggregate of Class A common stock and Class B common stock was approved as of July 15, 2025. The company said it intends to repurchase, from time to time, in the open market or otherwise, a combination of Class A common stock and Class B common stock, subject to market conditions and the market price of the company's stock.
US filing analysisUS8-K · Current reportPublished Sep 30, 2026SEC filing date Feb 12, 2026
KVUE
Kenvue said on February 10, 2026 that Amit Banati notified the company he will step down from his position as Chief Financial Officer, effective May 12, 2026.
US filing analysisUS8-K · Current reportPublished Oct 3, 2026SEC filing date Feb 12, 2026
FRT
Federal Realty Investment Trust said it issued supplemental data and a press release on February 12, 2026 to report its financial results for the quarter ended December 31, 2025.
US filing analysisUS8-K · Current reportPublished Oct 2, 2026SEC filing date Feb 12, 2026
DIS
The Walt Disney Company said on February 10, 2026 it entered into an Underwriting Agreement with Citigroup Global Markets Inc. and J.P. Morgan Securities LLC with respect to the offer and sale of 4 types of Notes.
US filing analysisUS8-K · Current reportPublished Oct 3, 2026SEC filing date Feb 12, 2026
C
Citigroup said the Compensation Committee determined the CEO Jane Fraser's compensation for 2025 performance at $42 million, consisting of a fixed base salary of $1.5 million and total incentive of $40.5 million.
US filing analysisUS8-K · Current reportPublished Oct 3, 2026SEC filing date Feb 12, 2026
ARE
Alexandria Real Estate Equities said that on February 10, 2026 it entered into an underwriting agreement with the representatives of the Underwriters and will sell $750,000,000 aggregate principal amount of 5.25% Senior Notes due 2036.
US filing analysisUS8-K · Current reportPublished Sep 30, 2026SEC filing date Feb 12, 2026
AMP
Ameriprise Financial announced on February 12, 2026 that Joseph E. Sweeney, President, Advice & Wealth Management Products & Service Delivery, has decided to retire from the company.
US filing analysisUS8-K · Current reportPublished Sep 30, 2026SEC filing date Feb 12, 2026
AME
AMETEK said on February 12, 2026 its Board of Directors approved a 10% increase in its quarterly cash dividend on common stock to $0.34 per share from $0.31 per share.
US filing analysisUS8-K · Current reportPublished Oct 3, 2026SEC filing date Feb 12, 2026
TMUS
T-Mobile said service revenues are expected to be approximately $77.0 billion in 2026 and $80.5 billion–$81.5 billion in 2027. Core Adjusted EBITDA is expected to be $37.0 billion–$37.5 billion in 2026 and $40.0 billion–$41.0 billion in 2027.
US filing analysisUS8-K · Current reportPublished Sep 30, 2026SEC filing date Feb 11, 2026
TECH
Bio-Techne said Dr. Matt McManus, President of its Diagnostics and Spatial Biology Segment, will transition from his role effective March 1, 2026 and will remain with the company for a period of time to support a smooth transition.
US filing analysisUS8-K · Current reportPublished Oct 3, 2026SEC filing date Feb 11, 2026
TDG
TransDigm Group said on February 10, 2026 it priced an aggregate of $2,000 million of new debt. The company said it intends to use the net proceeds of the new debt and cash on hand to fund the aggregate purchase price of the previously announced acquisitions and for related transaction fees and expenses.
US filing analysisUS8-K · Current reportPublished Sep 30, 2026SEC filing date Feb 11, 2026
ROL
Rollins said full-year 2025 revenues were $3.8 billion, up 11.0% from the prior year, operating income was $726 million, up 10.5%, and operating margin was 19.3%.
US filing analysisUS8-K · Current reportPublished Oct 2, 2026SEC filing date Feb 11, 2026
PEP
PepsiCo announced on February 4, 2026 an offering of €500,000,000 Floating Rate Notes due 2028, €650,000,000 3.300% Senior Notes due 2034, €850,000,000 3.700% Senior Notes due 2038 and €500,000,000 4.150% Senior Notes due 2047, with the Notes issued on February 11, 2026.
US filing analysisUS8-K · Current reportPublished Sep 30, 2026SEC filing date Feb 11, 2026
PANW
Palo Alto Networks said it completed the acquisition of CyberArk on February 11, 2026 pursuant to the Agreement and Plan of Merger dated July 30, 2025. Merger Sub merged with and into CyberArk, with CyberArk continuing as a wholly owned subsidiary of the company.
US filing analysisUS8-K · Current reportPublished Sep 30, 2026SEC filing date Feb 11, 2026
MRNA
Moderna said on February 3, 2026 that the FDA's Center for Biologics Evaluation and Research (CBER) notified the company it will not initiate a review of the biologics license application (BLA) for its investigational influenza vaccine mRNA-1010 and has issued a Refusal-to-File letter.
US filing analysisUS8-K · Current reportPublished Sep 30, 2026SEC filing date Feb 11, 2026
These reports are reference information based on public facts such as filings and prices. They do not recommend buying or selling any security.